Clinical trial
Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
NCT06603688 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 20, 2023
- Completion date
- December 1, 2024
- Enrollment
- 548 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic gastritis, helicobacter pylori infection